SARS-CoV-2 Semi-Quant IgG Ab – What Your Antibody Test Really Means The SARS-CoV-2 Semi-Quantitative IgG Antibody test is a blood test that measures the level of IgG antibodies your body has produced in response to the SARS-CoV-2 virus, the virus responsible for COVID-19. Unlike a qualitative test that gives a simple “positive” or “negative” result, this semi-quantitative test estimates the amount of antibody present and provides a numerical value — giving more detailed insight into your immune system’s response. What Are IgG Antibodies? Immunoglobulin G (IgG) antibodies are part of your body’s long-term immune defense system. After a person is exposed to a virus like SARS-CoV-2 — either through natural infection or vaccination — the immune system produces IgG antibodies to help fight off future infections. These antibodies typically appear within 1 to 3 weeks after infection or immunization and may remain in the blood for months or longer, although levels naturally decline over time. Why Is This Test Done? The SARS-CoV-2 Semi-Quant IgG Ab test is often used to: Determine if you've had a past COVID-19 infection, especially if you were asymptomatic or not tested at the time. Check for an immune response after vaccination, especially in people who are immunocompromised or at high risk. Track antibody levels over time, often as part of clinical studies or public health surveillance. Provide supporting evidence when evaluating suspected long COVID or post-viral complications. It is not used to diagnose an active COVID-19 infection. For that, you would need a PCR or antigen test. Understanding Your Results Positive or Elevated Result If your test shows detectable levels of SARS-CoV-2 IgG antibodies, it means your immune system has responded to the virus or vaccine. This result may indicate: A previous infection with SARS-CoV-2, even if you didn’t have symptoms. A successful immune response to a COVID-19 vaccine. Possible short-term immunity, though protection can vary by individual and over time. Your test may include a numerical value or index — higher numbers generally mean more antibodies, but there is no universally accepted "protective level" at this time. Negative or Low Result A negative or very low IgG antibody level suggests: No prior exposure to the virus or vaccine. The test was done too early, before your body had time to produce IgG antibodies. Antibody levels have waned over time, which is common and doesn’t necessarily mean you’re no longer protected. You may not have mounted a strong immune response due to immune suppression or chronic illness. Important Notes About Interpretation Antibody presence does not guarantee immunity. It’s one part of a complex immune system that also includes T-cells and memory B cells. The type of antibodies measured matters — some tests detect antibodies to the spike (S) protein (used in most vaccines), while others detect antibodies to the nucleocapsid (N) protein (which typically indicates natural infection). The semi-quantitative format provides a relative measure, not an exact titer. It's useful for tracking trends, not confirming full immunity. Do You Need Follow-Up? Most people don’t need follow-up unless: You’re immunocompromised and your doctor is monitoring your response to the vaccine. You're being evaluated for long COVID symptoms. You’re part of a study or work in a high-risk setting like healthcare. Your healthcare provider may recommend additional testing or booster shots depending on your results and risk factors. In Summary The SARS-CoV-2 Semi-Quant IgG Ab test gives a detailed look at your immune system's history with COVID-19. A positive result typically means you’ve developed antibodies through infection or vaccination, while a negative result suggests no prior exposure or a diminished immune response. While it can offer insight into your immune status, this test is not a direct measure of immunity and should always be interpreted with your clinical history and vaccination status in mind.

The SARS-CoV-2 Spike Antibody Dilution test measures the concentration of IgG antibodies that target the spike protein of SARS-CoV-2, the virus that causes COVID-19. Unlike a simple positive/negative test, this method uses dilution to accurately detect even very high antibody levels, offering a clearer picture of your immune response. What the Test Measures This test quantifies the amount of spike-specific antibodies in your blood. These antibodies usually develop after: COVID-19 vaccination (Pfizer, Moderna, Novavax, and others) Previous COVID-19 infection When antibody levels are very high—often after vaccination or a booster—standard antibody tests can reach their upper detection limit. Dilution testing “scales down” the sample so antibody levels can be measured precisely and reliably. What Your Results Can Tell You Antibody presence: Confirms that your immune system has responded to either vaccination or infection. Relative antibody level: Higher dilution values generally reflect higher concentrations of antibodies. Immune recognition: Shows your body can recognize the spike protein, which may help mount a faster response upon re-exposure. Risk insight: People with higher antibody levels often have lower risk of severe COVID-19, though protection varies by individual and viral variant. What These Results Do Not Show Exact protection: There is no universally defined antibody threshold that guarantees immunity. Timing of exposure: This test cannot determine when you were vaccinated or infected. Active infection: The dilution test does not diagnose current COVID-19 infection; other tests are needed for that purpose. Why Dilution Testing Matters Shortly after vaccination or booster shots, antibody levels can be so elevated that standard assays cannot measure them accurately. Diluting the sample ensures your result reflects the true concentration, rather than just reporting a “maximum.” This provides a more meaningful and actionable result for both patients and healthcare providers. Summary The SARS-CoV-2 Spike Antibody Dilution test offers a precise measurement of your antibody levels against the spike protein of COVID-19. Higher results typically suggest a stronger immune response from prior vaccination or infection. However, antibody levels alone do not guarantee full protection or lasting immunity. Continue to follow current public health recommendations, as antibodies are just one part of your body’s overall defense system.

SARS-CoV-2 Spike Ab Interp – Understanding Your COVID-19 Spike Protein Antibody Test The SARS-CoV-2 Spike Ab Interp refers to the interpretation of antibodies directed against the spike (S) protein of the virus that causes COVID-19. This marker is typically included in antibody panels to evaluate your immune response following infection with SARS-CoV-2 or after vaccination with COVID-19 vaccines that target the spike protein (such as Pfizer-BioNTech, Moderna, or Novavax). This test does not measure the antibody level itself, but instead provides an interpretation (positive, negative, equivocal) based on whether spike-specific antibodies are detected in your blood. What Is the Spike Protein and Why Does It Matter? The spike protein is the part of the SARS-CoV-2 virus that allows it to attach to and enter human cells. It’s also the main target of most COVID-19 vaccines, which are designed to teach the immune system to recognize and fight this viral protein. When you are: Infected with SARS-CoV-2, your body develops antibodies to several viral proteins, including the spike and nucleocapsid (N) proteins. Vaccinated, your immune system primarily develops antibodies only against the spike protein, since that’s what the vaccine presents. The SARS-CoV-2 Spike Ab Interp helps assess whether your immune system has mounted a spike-directed antibody response — which would be expected after vaccination or infection. What Does This Test Result Mean? Positive Spike Antibody Interpretation This means spike-specific IgG antibodies were detected in your blood. It suggests: A prior COVID-19 infection, or A successful immune response to a COVID-19 vaccine. It does not distinguish between infection and vaccination — additional testing (e.g., nucleocapsid antibody test) may be needed for that. A positive result may indicate some level of immune protection, though it’s important to understand that: Antibody presence does not equal guaranteed immunity. Other immune components (e.g., T-cells) also play a role. Protection may wane over time, depending on age, health, and exposure to variants. Negative Spike Antibody Interpretation This means spike antibodies were not detected. Possible reasons include: You have never been infected or vaccinated. You were recently exposed or vaccinated, and antibodies have not yet developed (usually takes 1–3 weeks). Your antibodies have declined over time, which is common. You have an impaired immune response, which can occur with immunosuppressive conditions or treatments. Equivocal or Indeterminate Result This suggests the antibody level is borderline, and may require: Repeat testing at a later time Additional immune evaluation Clinical correlation with symptoms or history How Is This Test Used? Doctors may order SARS-CoV-2 Spike Ab Interp for several reasons: To evaluate your response to a COVID-19 vaccine, especially in immunocompromised patients. To determine if you were previously infected, especially if you never had PCR testing at the time. To help assess whether a booster vaccine might be needed (though guidelines primarily rely on timing, not antibody levels). As part of clinical studies tracking immunity in populations. Limitations to Be Aware Of This test does not diagnose active COVID-19. PCR or antigen testing is needed for that. A positive result does not guarantee immunity against future infection. The test does not measure T-cell immunity, which also contributes to long-term protection. The results may not correlate perfectly with protection against new variants of the virus. Key Takeaways SARS-CoV-2 Spike Ab Interp gives you an interpretation of whether your immune system has made antibodies against the spike protein of the COVID-19 virus. A positive result suggests prior infection or vaccination. A negative result may indicate no prior exposure, a weak immune response, or the need for more time after vaccination. The result should be interpreted in context — along with your vaccination history, symptoms, timing, and immune health.

Saturated Fats, Total is a key marker providing important information about the levels of saturated fats in your diet. Saturated fats are a type of fat found in various foods, including animal products like meat and dairy, as well as some plant-based oils like coconut and palm oil and peanut butter. These fats are typically solid at room temperature. Monitoring the total amount of saturated fats in your diet is crucial because high intake is linked to an increased risk of developing heart disease and other health issues. When you consume too many saturated fats, it can lead to higher levels of LDL (low-density lipoprotein) cholesterol, often referred to as "bad" cholesterol, in your blood. This can cause fatty deposits to build up in your arteries, narrowing them and making it harder for blood to flow through. Over time, this increases the risk of heart attacks, strokes, and other cardiovascular diseases. The Nutristat Basic Profile measures the total amount of saturated fats you consume to help you understand and manage your dietary intake. By keeping track of this marker, you can make informed dietary choices, such as opting for leaner cuts of meat, low-fat dairy products, and healthier cooking oils like olive oil. Reducing your intake of saturated fats can significantly improve your overall health and lower your risk of heart disease.

When assessing fatty acids in RBCs, this marker measures a weighted percentage of fatty acids taken up into the erythrocyte wall. The total saturated fatty acid percentage is a combined total weight percentage calculated by adding up each of the measured saturated fatty acids. It should be noted that when dealing with percentages, the amount of each fatty acid can influence the others. For example, fish oil supplementation may increase the overall omega-3 percentage, which then lowers the omega-6 percentage. Because some saturated fatty acids are beneficial, it is important to look at the levels of those specifically as well. Fatty acids are essential to heart health. Balancing fatty acids can improve cholesterol and triglyceride levels, improve immune system function as well as reduce inflammation and rate of heart disease. Saturated Fatty Acid Index Includes: Myristic (14:0) Palmitic (16:0) Stearic (18:0) - May raise levels of LDL-C and increases heart disease risk.

Scallop IgE
Serum

The Scallop (F338) IgE test measures your immune system’s sensitivity to proteins found in scallops — a type of shellfish belonging to the mollusk family. This test specifically detects immunoglobulin E (IgE) antibodies that your body may produce in response to scallop allergens. When someone with a scallop allergy eats scallops (or sometimes even comes into contact with them through cooking vapors or cross-contaminated utensils), their immune system can mistakenly identify scallop proteins as harmful. This triggers an IgE-mediated allergic reaction, releasing histamine and other chemicals that cause allergy symptoms.

Reference Ranges: Negative: Less than 0.20 OD. No significant level of IgG antibody to Schistosoma detected. Indeterminate: 0.20 to 0.49 OD. It is recommended to repeat the assay with a paired sample after at least one month, when the results fall within this range. Positive: Greater than or equal to 0.50 OD. Presumptive evidence of a current or past infection with Schistosoma species. Serological results should be used as an aid in diagnosis and should not be interpreted as diagnostic by themselves. The Schistosoma IgG Antibody marker on a panel from Labcorp is a diagnostic tool used to detect antibodies against Schistosoma, a type of parasitic worm that causes schistosomiasis. When someone is infected with Schistosoma, their immune system responds by producing specific antibodies, including IgG. The presence of Schistosoma IgG antibodies in a blood sample indicates that the person has been exposed to the parasite. This exposure could be recent or from a past infection since IgG antibodies can remain in the bloodstream for a long time. The test does not differentiate between current or past infections but provides valuable information about exposure. This is particularly useful in diagnosing schistosomiasis, especially in individuals who have traveled to or lived in areas where the parasite is common, such as parts of Africa, South America, the Caribbean, the Middle East, and Southeast Asia. Symptoms of schistosomiasis can include abdominal pain, diarrhea, blood in the urine or stool, and chronic infections can lead to more severe complications like liver damage, kidney failure, or bladder cancer. Therefore, a positive Schistosoma IgG Antibody test helps healthcare providers understand if schistosomiasis might be the cause of these symptoms, guiding further testing and treatment decisions. A negative result for the Schistosoma IgG Antibody test indicates that there are no detectable IgG antibodies against Schistosoma in the person's blood. This suggests that the individual has not been exposed to the Schistosoma parasite or that any previous exposure did not lead to a significant immune response detectable by the test. It is important to note, however, that a negative result does not completely rule out the possibility of a very recent infection, as it can take several weeks for IgG antibodies to develop to detectable levels. Therefore, if there is a strong suspicion of schistosomiasis based on symptoms or exposure history, additional tests or follow-up testing might be recommended. A negative result can be reassuring for individuals who have not been in regions where Schistosoma is prevalent or who do not have symptoms consistent with schistosomiasis.